Strategy Driven

JUNE 22, 2018

It’s a sure sign that the products or services that you are offering are quality and that you are providing customer satisfaction. When your operational and back office processes are aligned you work efficiently and productively. Here are 5 signs that you are ready to expand: 1. You have a loyal customer base. You identify gaps.

Audience 50

Audience Niche Marketing How To Marketing Strategy 50

Strategy Driven

JULY 13, 2011

It turned out that the unit was driving profits by raising prices and cutting marketing and advertising expenditures. Higher prices and reduced advertising created an opening for competitors to take away market share, which they did. So while profits were rising and ROIC was high, market share was declining.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

JULY 23, 2015

For years, there has been a push within the pharmaceutical industry to move “beyond the pill” — in other words, to build and deploy complementary services and solutions to diversify revenue sources. However, many beyond-the-pill efforts have sputtered or died. Regulatory environment.

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Committee 8

Strategy Driven

MARCH 18, 2011

In The Essential Advantage : How to Win with a Capabilities-Driven Strategy , Booz & Company’s Paul Leinwand and Cesare Mainardi maintain that success in any market accrues to firms with a coherence premium – a tight match between their strategic direction and the capabilities that make them unique. Let’s go after it.”

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In contrast, emerging-market VCs such as Nadathur Holdings (established in 2000 by N.S.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

DECEMBER 23, 2016

When partners in an alliance come into conflict, it can be just what is needed to produce a technically and commercially successful product. ” Members from each partner organization rate the alliance in areas related to strategic fit, operational fit, and cultural fit. The results were fascinating.

Productivity 8

Productivity Products Survey Strategic Fit 8

Harvard Business Review

JUNE 13, 2016

No matter how you look at it, there have been terrible, unintended outcomes from the introduction and marketing of next-generation prescription opioids. Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. And what can we learn from it?

Incentives 8

Incentives Pharmaceuticals Crisis P&L 8

Harvard Business Review

AUGUST 3, 2016

That can benefit consumers through lower prices, more innovation, and better products. On the other hand, M&As can also strengthen the market power of the combined entity, reducing competition in a way that harms consumers. It’s far easier to predict short-run changes in prices and quantities in the current market.

Innovation 8

Innovation Pharmaceuticals Company Price 8

Harvard Business Review

AUGUST 14, 2018

Many leading American digital firms, including Google, Amazon, eBay, and Uber, have successfully expanded internationally by introducing their products, services, and platforms in other countries. However, they have all failed in China, the world’s largest digital market. market on China. market on China.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

MAY 26, 2016

Operating margins for firms publicly listed in the US show a substantial and sustained rise. Firms engage in political “rent seeking”—lobbying for regulations that provide them sheltered markets—rather than competing on innovation. If so, then high profits portend diminished productivity growth.

Pharmaceuticals 10

Pharmaceuticals Politics Price Chemicals 10

Harvard Business Review

MAY 20, 2014

financial services sector went from 13,000 of independent banks to half that number, while the top ten banks grew from 20% market share to 60%. As of 2013, the top ten banks had 70% of the market. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. In the guitar business , too.

Pharmaceuticals 10

Pharmaceuticals Banking Chemicals Trends 10

Harvard Business Review

MARCH 11, 2013

And today the company has become more open in a number of areas, as the pressures of the market forces are forcing it to open up even further. Yes, Apple is obviously super-secretive with its customers about product announcements. That can be a powerful marketing technique if you have the market muscle to pull it off.

Supply Chain 15

Supply Chain Open-book Software Niche Marketing 15

Harvard Business Review

JULY 28, 2015

Let’s look at a few examples of powerful summaries: “Pharmaceutical marketing executive with 20 years of experience creating commercial infrastructures, growing brands, and optimizing product value throughout launch, re-launch, and sunset life cycles across all customer segments—payers, physicians, and patients.

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

OCTOBER 26, 2017

Nowadays, when a multitude of businesses are confronted with the leap from “dumb” products to creating smart, connected ones , and cities and regions are trying to make the leap from manufacturing to services, relying too heavily on past successes will only lock those clusters in the past. Moreover, a cluster can never be static.

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

OCTOBER 20, 2016

As a practical matter, for example, these changes in the global policy regime are forcing multinational corporations to scale back and sell parts of their international operations. Imports among the world’s 20 largest economies have fallen as a share of their gross domestic product for four consecutive years. at the forefront.

Globalization 8

Globalization Banking Policies Politics 8

Harvard Business Review

FEBRUARY 16, 2017

Most businesses wouldn’t survive without driving demand for their products or services, either through marketing and advertising or through involving users so deeply in the design of the product that word of mouth spurs adoption. Develop and fund a sales and marketing capability from the outset.

Innovation 9

Innovation Rogers NGO Participative 9

Harvard Business Review

MARCH 27, 2018

Apple and Google, for example, each control a popular mobile phone operating system platform (and key apps on that platform), Amazon controls the largest online merchant platform, and Facebook controls the largest social network platform. He noted his agency’s “particular concerns in digital markets.” In the U.S.,

Company 11

Company Advertising Incentives Engineering 11

Harvard Business Review

APRIL 2, 2018

health care system, ranging from expensive imaging for benign medical conditions to routine pre-operative testing before low-risk surgeries like cataract surgery. Mortgages exist to spread the costs of a home or a car out over a longer period of time, thereby allowing people to buy a product that they otherwise could not afford.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

NOVEMBER 30, 2017

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. It’s clear why pain in the domestic supplier base matters from a policy perspective.

Supply Chain 8

Supply Chain McKinsey Incentives Bottom-up 8

Harvard Business Review

MAY 7, 2015

What happened is very well documented: they kept running down the maintenance budget, pushing their operating budget to make their numbers. Meanwhile, I had a lot friends and colleagues saying, “The capital markets are a huge problem.” the capital markets are much stickier. Insight Center. The New Ways to Compete.

Short-term 8

Short-term Henderson Long-term Metrics 8

Harvard Business Review

AUGUST 24, 2017

We focused on nine common types of corporate litigation: antitrust, employment civil rights, contract, environmental, intellectual property, labor, personal injury, product liability, and securities. We predicted that the market would reward firms with lawyer CEOs, who would be better able to navigate the new regulatory environment.

CEO 8

CEO Accrual Accounting Pharmaceuticals Banking 8

Harvard Business Review

NOVEMBER 24, 2015

The most common source of joint value is economies of scale , which allow for a reduction in the costs of either production or back-office operations. Economies of scale in production are often limited to the factory level; that is, they come from larger factories, not necessarily from larger firms.

Pharmaceuticals 8

Pharmaceuticals Cost Airlines Productivity 8

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare. What do you think?

COO 12

COO Sample Telecommunications Automotive 12

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. For example, printing products on demand would significantly reduce the U.S. What happens, for example, if the value of a product’s underlying intellectual property overtakes its production value?

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

JANUARY 13, 2015

Nearly all competitive markets confront firms with this choice. In pharmaceuticals, there are blockbuster drugs targeted at mass-markets segments. Here, your product or service provides better performance on attributes that are important to target customers and for which they are willing to pay a premium. billion in 2014.

Market Segmentation 8

Market Segmentation Mass Marketing Price Pharmaceuticals 8

Harvard Business Review

MAY 5, 2016

But peruse some of the recent headlines about Iran , and you might wonder whether the market’s potential was overstated. However, despite a weakened economy, political tensions, market uncertainty, and the lingering effects of sanctions, Iran remains an important opportunity for multinationals in emerging markets.

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

OCTOBER 25, 2018

We focus on economic profit rather than revenue size, market share, or productivity growth because these other metrics risk including firms that are simply large and may not create economic value. Productivity can help; but it is not enough to achieve superstardom.

Industry 12

Industry Company GDP Bottom-up 12

Harvard Business Review

OCTOBER 26, 2015

A recent USC study shows that across multiple and diverse markets, industries are 25% more likely to be “highly concentrated” than they were 20 years ago. Yet at the same time, America’s largest companies are more than twice as likely to lose market share than in 1980. corporate consolidation.

Competitive Advantage 8

Competitive Advantage Pharmaceuticals Industry Trends 8

Harvard Business Review

DECEMBER 18, 2014

It used to be that hospitals and health systems operated as islands, selecting and purchasing medical supplies, devices and medications in isolation, and keeping their operational and leadership practices to themselves. While collaboration is always challenging, the health care benefits are by now clear.

Health Care 8

Health Care Retail Mayo Pharmaceuticals 8

Harvard Business Review

JANUARY 13, 2014

Nevertheless, you still have to plan for it, even when you don’t know precisely what’s it going to be – what your market will look like, how technology might evolve, and how your competition might respond. But what happens when you want to look beyond today and examine your rivals or your market a few years from now?

Uncertainty 8

Uncertainty Pharmaceuticals Industry Marketing 8

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. They’re also sharing risk. The new business model has yet to solidify, and the leaders have yet to emerge. The positions are there for the taking. But not for long. The options are tangible.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity. Demand is Shifting.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. Are we going to have to work really hard to differentiate the product or products that result from the acquisition? billion tender offer directly to shareholders.

Innovation 13

Innovation Company Biotechnology CFO 13

In the CEO Afterlife

JUNE 19, 2011

A Boomer’s Advice to Marketers: Go Ahead, Make My Day. by John • June 19, 2011 • Life , Marketing , Strategy • 1 Comment. Today, we represent a marvelous marketing opportunity. We operate by the mantra of “use it or you lose it.” Aha,” say the savvy marketers. In the CEO Afterlife. Leadership.

Advice 147

Advice Marketing Marketing Strategy Brand 147

Harvard Business Review

MARCH 11, 2013

And today the company has become more open in a number of areas, as the pressures of the market forces are forcing it to open up even further. Yes, Apple is obviously super-secretive with its customers about product announcements. That can be a powerful marketing technique if you have the market muscle to pull it off.

Supply Chain 8

Supply Chain Open-book Software Niche Marketing 8

Harvard Business Review

MAY 16, 2011

True collaboration always has open-ended elements — ranging from precisely how new innovations will be implemented, to how products will fare in the market, and even to what priorities partners will pursue in the face of changes in the environment. Google uses a different approach to working with multiple external parties.

Software 15

Software Licensing Long-term Telecommunications 15